Schedule 13G ownership disclosure
UROGEN PHARMA LTD
Ordinary Shares · CUSIP: M96088105
Event date: 2024-12-31
- Filing-level shares
- 752,861
- Percent of class
- 1.8%
- Morgan Stanley
Shares: 752,861 · Class: 1.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-25-000235
- Form type
- SCHEDULE 13G/A
- Filer
- MORGAN STANLEY
- CIK
- CIK 895421
- Filed
- Feb 05, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership